
DSM Venturing
Description
DSM Venturing is the corporate venture capital arm of Royal DSM, a global science-based company specializing in Nutrition, Health, and Sustainable Living. Established in 2001, DSM Venturing plays a crucial role in Royal DSM's innovation strategy by identifying and investing in promising startups that align with its core business areas. The firm operates globally, seeking out disruptive technologies and business models that can complement DSM's existing capabilities and accelerate its growth in new and emerging markets. Its strategic objective is not merely financial return but also to foster synergistic partnerships that can lead to joint development, market access, and the integration of new technologies into DSM's product portfolio.
The investment focus of DSM Venturing is tightly aligned with Royal DSM's strategic pillars. This includes startups innovating in human nutrition and health, such as personalized nutrition, gut health, and early life nutrition. They also target advancements in animal nutrition and health, including sustainable feed ingredients and animal welfare solutions. Furthermore, DSM Venturing actively invests in sustainable living solutions, encompassing bio-based materials, renewable energy technologies, and circular economy initiatives. The firm typically engages with companies across various stages, from seed and Series A rounds to Series B and growth-stage investments, demonstrating flexibility in its funding approach to support companies through their development lifecycle.
As a strategic investor, DSM Venturing provides more than just capital. Portfolio companies gain access to Royal DSM's extensive scientific expertise, state-of-the-art research and development facilities, and a vast global network of industry contacts. This hands-on approach helps startups scale their operations, navigate regulatory landscapes, and accelerate market penetration. While specific check sizes can vary based on the stage and needs of the company, DSM Venturing's typical first cheque ranges from approximately $1 million to $10 million, reflecting their commitment to significant early-stage and growth-stage contributions. The firm has made over 80 investments since its inception, underscoring its active role in the venture ecosystem.
This strategic investment model allows Royal DSM to stay at the forefront of innovation, integrating cutting-edge solutions into its offerings while providing critical support to entrepreneurial ventures. DSM Venturing's long-standing presence and focused investment strategy make it a key player in fostering innovation within the nutrition, health, and sustainable living sectors globally.
Investor Profile
DSM Venturing has backed more than 87 startups, with 1 new investments in the last 12 months alone. The firm has led 46 rounds, about 53% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Series B rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands, Canada.
- Strong thematic focus on Health Care, Biotechnology, Manufacturing.
- Typical check size: $1M – $10M.
Stage Focus
- Series A (33%)
- Series Unknown (25%)
- Series B (17%)
- Series C (9%)
- Seed (8%)
- Convertible Note (2%)
- Post Ipo Equity (2%)
- Undisclosed (1%)
- Pre Seed (1%)
Country Focus
- United States (55%)
- The Netherlands (13%)
- Canada (8%)
- United Kingdom (8%)
- Israel (6%)
- Denmark (3%)
- Belgium (2%)
- France (2%)
- Germany (1%)
- Saudi Arabia (1%)
Industry Focus
- Health Care
- Biotechnology
- Manufacturing
- Food And Beverage
- Wellness
- Medical Device
- Nutrition
- Dietary Supplements
- Medical
- Food Processing
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.